Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

|Videos|July 1, 2021

Dr. Casey Seideman on underrepresentation of women in AUA prestigious recognition awards

Author(s)Urology Times staff

Casey Seideman, MD, discusses her research study published in the Journal of Urology, which showed that although women represent an increasing percentage of the urology workforce, they continue to be underrepresented in receiving recognition awards from the American Urological Association. Seideman is assistant professor of Urology, School of Medicine, Oregon Health & Science University.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

University of Florida chief residents discuss mentorship, self-care, and residency success

ByMiranda Eubank, MD,Trisha U. Nguyen, MD,Jordan Matthews-Smith, MD

July 15th 2026

Pearls & Perspectives: Bridging Gaps in Functional Urology Care, With Diane Newman, DNP, FAAN, BCB-PMD, and Stuart Hart, MD, MBA, MS

ByAmy M. Pearlman, MD,Larry Lipshultz, MD,Diane K. Newman, DNP, FAAN, BCB-PMD,Stuart Hart, MD, MBA, MS

July 7th 2026

The UroOnc Minute: Making Appointments More Effective, With David Canes, MD

ByAdam B. Weiner, MD,David Canes, MD

July 3rd 2026

Pearls & Perspectives: The Power of Advocacy in Sexual Medicine, With Rachel Rubin, MD

ByAmy M. Pearlman, MD,Larry Lipshultz, MD,Rachel Rubin, MD

June 23rd 2026

Pearls & Perspectives: The Evolving Landscape of Female Pelvic Health, With Annah J. Vollstedt, MD

ByAmy M. Pearlman, MD,Annah J. Vollstedt MD

June 9th 2026

Latest CME

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC

Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation

First-in-human bladder transplant demonstrates sustained function at 6 months

Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC

Department of Defense announces annual testosterone deficiency screening for service members